☆ 4.7 Letter

Artificial intelligence (AI) is paving the way for a critical role in drug discovery, drug design, and studying drug-drug interactions - correspondence

INTERNATIONAL JOURNAL OF SURGERY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

Machine learning models for predicting the activity of AChE and BACE1 dual inhibitors for the treatment of Alzheimer's disease

G. Dhamodharan et al.

Summary: This study developed multi-target directed ligand-based 2D-QSAR models for AChE and BACE1 inhibitors using various molecular descriptors and machine learning methods. Statistically significant models were successfully developed for predicting the inhibitory activity of both enzymes, showcasing the importance of specific molecular descriptors in rational drug design for Alzheimer's disease.

MOLECULAR DIVERSITY (2022)

添加到收藏夹

Review Chemistry, Multidisciplinary

Machine learning in drug design: Use of artificial intelligence to explore the chemical structure-biological activity relationship

Maciej Staszak et al.

Summary: The paper provides a comprehensive overview of the use of artificial intelligence systems, particularly neural networks, in drug design to identify chemical structures with medical relevance. Successful training of neural networks requires a large set of training data related to the chemical structure-biological activity relationship, which can be obtained from experimental measurements or appropriate quantum models. Recent advancements in computing power have led to rapid development in neural network systems and a growing interest in deep learning techniques, allowing for a new level of abstraction in network modeling.

WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Application of Artificial Intelligence in Drug Discovery

Hitesh Chopra et al.

Summary: Modern drug discovery has shifted towards big data, with the help of Artificial intelligence making drug discovery more precise and knowledgeable. Pharmaceutical companies have started a race to find new drugs, with AI predicting compound characteristics, saving time and resources.

CURRENT PHARMACEUTICAL DESIGN (2022)

添加到收藏夹

Article Biochemical Research Methods

CNN-DDI: a learning-based method for predicting drug-drug interactions using convolution neural networks

Chengcheng Zhang et al.

Summary: The study proposes a novel algorithm using a CNN architecture to predict drug-drug interactions. The algorithm extracts feature interactions from drug categories, targets, pathways, and enzymes to build a convolution neural network as the predictor. The results show that drug categories are effective as a new feature type in the CNN-DDI method.

BMC BIOINFORMATICS (2022)

添加到收藏夹

Review Biology

Accelerating antibiotic discovery through artificial intelligence

Marcelo C. R. Melo et al.

Summary: Antibiotics insert themselves into the ancient struggle of host-pathogen evolution, driving urgent interest in computational methods for candidate discovery. Advances in artificial intelligence have been applied to antibiotic discovery, emphasizing antimicrobial activity prediction, drug-likeness traits, resistance, and de novo molecular design. Best practices such as open science and reproducibility are crucial in accelerating preclinical research in the face of antimicrobial resistance crisis.

COMMUNICATIONS BIOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Artificial intelligence to deep learning: machine intelligence approach for drug discovery

Rohan Gupta et al.

Summary: Drug designing and development faces challenges in terms of low efficacy, high cost, and complexity of data. However, artificial intelligence and machine learning technologies play a crucial role in overcoming these challenges and advancing the field.

MOLECULAR DIVERSITY (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Prediction of drug efficacy from transcriptional profiles with deep learning

Jie Zhu et al.

Summary: The study introduces a deep learning-based efficacy prediction system that identifies drug candidates based on changes in gene expression profiles in diseased states. The system was successfully validated on three disorders and showed high predictive accuracy, providing insights into drug repurposing and discovery.

NATURE BIOTECHNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Powerful antibiotics discovered using AI

Jo Marchant

NATURE (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Capsule Networks Showed Excellent Performance in the Classification of hERG Blockers/Nonblockers

Yiwei Wang et al.

FRONTIERS IN PHARMACOLOGY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: MolecularDe NovoDesign, Dimensionality Reduction, andDe NovoPeptide and Protein Design

Eugene Lin et al.

MOLECULES (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Artificial intelligence in drug discovery and development

Debleena Paul et al.

DRUG DISCOVERY TODAY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

RPITER: A Hierarchical Deep Learning Framework for ncRNA-Protein Interaction Prediction

Cheng Peng et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

Multi-channel PINN: investigating scalable and transferable neural networks for drug discovery

Munhwan Lee et al.

JOURNAL OF CHEMINFORMATICS (2019)

添加到收藏夹

Article Chemistry, Medicinal

Boosting Docking-Based Virtual Screening with Deep Learning

Janaina Cruz Pereira et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)

添加到收藏夹

Article Chemistry, Medicinal

MOARF, an Integrated Workflow for Multiobjective Optimization: Implementation, Synthesis, and Biological Evaluation

Nicholas C. Firth et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.